369 related articles for article (PubMed ID: 28364922)
1. Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.
Luzze H; Badiane O; Mamadou Ndiaye EH; Ndiaye AS; Atuhaire B; Atuhebwe P; Guinot P; Fry Sosne E; Gueye A
Vaccine; 2017 Apr; 35(17):2141-2147. PubMed ID: 28364922
[TBL] [Abstract][Full Text] [Related]
2. The imperative for stronger vaccine supply and logistics systems.
Zaffran M; Vandelaer J; Kristensen D; Melgaard B; Yadav P; Antwi-Agyei KO; Lasher H
Vaccine; 2013 Apr; 31 Suppl 2():B73-80. PubMed ID: 23598495
[TBL] [Abstract][Full Text] [Related]
3. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
4. National logistics working groups: A landscape analysis study.
Leab D; Schreiber B; Kasonde M; Bessat O; Bui S; Loisel C
Vaccine; 2017 Apr; 35(17):2233-2242. PubMed ID: 28364937
[TBL] [Abstract][Full Text] [Related]
5. Transforming vaccines supply chains in Nigeria.
Sarley D; Mahmud M; Idris J; Osunkiyesi M; Dibosa-Osadolor O; Okebukola P; Wiwa O
Vaccine; 2017 Apr; 35(17):2167-2174. PubMed ID: 28364926
[TBL] [Abstract][Full Text] [Related]
6. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.
Adjagba A; Senouci K; Biellik R; Batmunkh N; Faye PC; Durupt A; Gessner BD; da Silva A
Vaccine; 2015 Jan; 33(5):588-95. PubMed ID: 25545597
[TBL] [Abstract][Full Text] [Related]
7. The people factor: An analysis of the human resources landscape for immunization supply chain management.
Kasonde M; Steele P
Vaccine; 2017 Apr; 35(17):2134-2140. PubMed ID: 28364921
[TBL] [Abstract][Full Text] [Related]
8. Transforming cold chain performance and management in lower-income countries.
Brison M; LeTallec Y
Vaccine; 2017 Apr; 35(17):2107-2109. PubMed ID: 28364916
[TBL] [Abstract][Full Text] [Related]
9. The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda.
Howard N; Walls H; Bell S; Mounier-Jack S
Vaccine; 2018 Sep; 36(37):5536-5543. PubMed ID: 30076103
[TBL] [Abstract][Full Text] [Related]
10. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
[TBL] [Abstract][Full Text] [Related]
11. Global support for new vaccine implementation in middle-income countries.
Kaddar M; Schmitt S; Makinen M; Milstien J
Vaccine; 2013 Apr; 31 Suppl 2():B81-96. PubMed ID: 23598496
[TBL] [Abstract][Full Text] [Related]
12. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
13. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
14. Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.
Eriksson P; Gessner BD; Jaillard P; Morgan C; Le Gargasson JB
Vaccine; 2017 Apr; 35(17):2155-2161. PubMed ID: 28364924
[TBL] [Abstract][Full Text] [Related]
15. Improving cold chain systems: Challenges and solutions.
Ashok A; Brison M; LeTallec Y
Vaccine; 2017 Apr; 35(17):2217-2223. PubMed ID: 27670076
[TBL] [Abstract][Full Text] [Related]
16. What vaccine product attributes do immunization program stakeholders value? Results from interviews in six low- and middle-income countries.
Kristensen DD; Bartholomew K; Villadiego S; Lorenson K
Vaccine; 2016 Dec; 34(50):6236-6242. PubMed ID: 27836438
[TBL] [Abstract][Full Text] [Related]
17. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
18. Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges.
Gordon WS; Jones A; Wecker J
Health Policy Plan; 2012 May; 27 Suppl 2():ii17-26. PubMed ID: 22513729
[TBL] [Abstract][Full Text] [Related]
19. Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.
Bell S; Blanchard L; Walls H; Mounier-Jack S; Howard N
Health Policy Plan; 2019 May; 34(4):271-281. PubMed ID: 31074778
[TBL] [Abstract][Full Text] [Related]
20. Introduction of new vaccines: decision-making process in Bangladesh.
Uddin J; Sarma H; Bari TI; Koehlmoos TP
J Health Popul Nutr; 2013 Jun; 31(2):211-7. PubMed ID: 23930339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
